Conclusion: AT significantly improves TTP and ORR compared with AC in patients with MBC, but there is no difference in OS. AT represents a valid option for the treatment of MBC. From the University of ...

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse Patients were eligible if they had stage I to III operable ...

Dr. Lisa Carey answers the question: 'Drugs, Schedules For Chemo Treatments?' — -- Question: What kinds of drugs, timetables and possible side effects can be expected with the following commonly ...

Adding an anthracycline to adjuvant chemotherapy for TOP2A-normal early breast cancer significantly improved disease-free survival (DFS) but not overall survival (OS) at 10 years, and doubled the risk ...

September 16, 2008 (Stockholm, Sweden) — The addition of docetaxel (Taxotere, Sanofi Aventis) to a traditional anthracycline-based regimen significantly improved both relapse-free survival and overall ...

One method for increasing dose intensity in high risk patients in order to achieve the most benefit of maximum dose intensity is reducing the conventional drug dose intervals dose-dense regimen.

In this video, Coral Omene, MD, PhD, assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, and program director of Breast Cancer Disparities Research in the division of ...

Pictured below is a woman with microscopic polyangiitis treated with intravenous cyclophosphamide and high doses cytoxan price in india corticosteroids. After several cyclophosphamide treatments. When ...